𝔖 Bobbio Scriptorium
✦   LIBER   ✦

INCIDENCE OF ADVANCED PROSTATE CANCER IN THE FINNISH PROSTATE CANCER SCREENING TRIAL

✍ Scribed by Tammela, Teuvo L; Martikainen, Paula; Stenman, Ulf-Hakan; Ruutu, Mirja; Hakama, Matti; Auvinen, Anssi

Book ID
122510266
Publisher
Lippincott Williams and Wilkins
Year
2008
Tongue
English
Weight
207 KB
Volume
179
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate cancer and PSA among statin use
Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial
✍ Teemu J. Murtola; Teuvo L.J. Tammela; Liisa Määttänen; Heini Huhtala; Elizabeth 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 177 KB 👁 1 views

## Abstract Decreased risk of advanced prostate cancer has been reported among men using statins. However, the evidence on overall prostate cancer risk is conflicting. We compared the relative risk between current users and non‐users of statins or other cholesterol‐lowering medications in a populat

Results of the three rounds of the Finni
Results of the three rounds of the Finnish Prostate Cancer Screening Trial—The incidence of advanced cancer is decreased by screening
✍ Tuomas P. Kilpeläinen; Anssi Auvinen; Liisa Määttänen; Paula Kujala; Mirja Ruutu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 299 KB 👁 1 views

## Abstract Screening for prostate cancer (PC) remains a controversial issue despite some new evidence on the mortality benefits of PC screening. We conducted a prospective, randomized screening trial in Finland to investigate whether screening decreases PC incidence. Here, we report the incidence

Biological aggressiveness of prostate ca
Biological aggressiveness of prostate cancer in the Finnish screening trial
✍ Marita Laurila; Teuvo L.J. Tammela; Anssi Auvinen; Jorma Isola; Tapio Visakorpi; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 184 KB 👁 1 views

## Abstract Prostate cancer aggressiveness was evaluated based on pathologic characterization of cases detected in the Finnish prostate cancer screening trial. The trial population consists of 80,458 men aged 55–67 years. A total of 32,000 men were randomized to the screening arm. The remaining 48,